Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Alpha, Beta Unsaturated Amide. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112142617A details a novel oxidative carbonylation method for synthesizing alpha,beta-unsaturated alkynamides with high selectivity and recyclable catalysts.
Patent CN110818584B reveals a metal-free visible light method for synthesizing alpha,beta-unsaturated amides, offering cost reduction and scalable pharmaceutical intermediate manufacturing.
Patent CN113896648B reveals nickel-catalyzed synthesis avoiding toxic CO gas. Delivers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Novel nickel-catalyzed method using nitroarenes as nitrogen source enables sustainable pharmaceutical intermediate production with enhanced supply chain reliability.
Innovative nickel-catalyzed method eliminates toxic CO gas and expensive catalysts while enabling scalable production of high-purity pharmaceutical intermediates with broad substrate tolerance.
Novel nickel-catalyzed method eliminates CO gas using molybdenum carbonyl for high-purity API intermediates with scalable production and reduced lead time.
Solve supply chain risks in amide synthesis: New molybdenum carbonyl method eliminates toxic CO gas, uses cheap nitroarenes, and achieves high yields for pharma intermediates.
Tired of toxic CO gas in amide synthesis? Discover emerging nickel-catalyzed routes using nitroarenes as nitrogen source. Find reliable suppliers for high-purity alpha, beta-unsaturated amides.